Re: ACC 2019?
|
3
|
Resverlogix Corp.
|
Dec 07, 2018 10:50AM
|
Re: National Kidney Foundation -Abstract: BOM
|
3
|
Resverlogix Corp.
|
Mar 30, 2020 03:17PM
|
Re: Competition
|
3
|
Resverlogix Corp.
|
Nov 28, 2021 01:56PM
|
Re: NASDAQ here we come!!!
|
3
|
Resverlogix Corp.
|
Apr 23, 2019 04:34PM
|
Re: Still not finding on ClinicalTrials gov
|
3
|
Resverlogix Corp.
|
Apr 22, 2021 05:15AM
|
AGM 2024
|
3
|
Resverlogix Corp.
|
Apr 19, 2024 07:12AM
|
Re: Hmmm....
|
3
|
Resverlogix Corp.
|
May 02, 2019 10:47AM
|
Re: For what it’s worth
|
3
|
Zenith Epigenetics
|
Jul 19, 2023 10:40AM
|
Re: Tweet from Prof Kausik Ray
|
3
|
Resverlogix Corp.
|
Jun 02, 2020 08:05AM
|
Re: Short interest
|
3
|
Resverlogix Corp.
|
Apr 02, 2021 03:31PM
|
Additional Exempt Distribution- 2023-04-28
|
3
|
Zenith Epigenetics
|
May 09, 2023 09:33AM
|
Re: Question for posters
|
3
|
Resverlogix Corp.
|
Dec 10, 2021 07:12AM
|
Re: Interesting Trades / Volume .....
|
3
|
Resverlogix Corp.
|
Jan 27, 2019 05:57AM
|
Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension
|
3
|
Resverlogix Corp.
|
Jul 31, 2024 06:42PM
|
Additional Reports of Exempt Distribution
|
3
|
Zenith Epigenetics
|
Mar 18, 2023 11:39AM
|
Re: Lu stepping down
|
3
|
Resverlogix Corp.
|
Apr 25, 2024 04:08PM
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
3
|
Resverlogix Corp.
|
Mar 18, 2022 12:41PM
|
Re: Looks like 0 participation in warrant incentive imo - answer to my email...
|
3
|
Resverlogix Corp.
|
Jan 18, 2020 04:26PM
|
Re: if we don't hit.75 to a $1.00 or more today
|
3
|
Resverlogix Corp.
|
Jun 09, 2020 02:24PM
|
Re: "Actively Recruiting" ?
|
3
|
Resverlogix Corp.
|
Nov 04, 2021 03:28PM
|